Association between site‐specific bone mineral density and glucose homeostasis and anthropometric traits in healthy men and women

Patients with type 2 diabetes mellitus have an increased risk of fracture despite normal or increased bone mineral density (BMD). Studies on the relationship of glucose homeostasis with BMD phenotypes have been inconclusive because distinguishing the roles of insulin resistance and hyperglycaemia in bone remodelling is challenging. In this study, we sought to define the relationship of site‐specific BMD with glucose homeostasis traits and anthropometric traits.

[1]  J. Gustafsson,et al.  Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Tuan V. Nguyen,et al.  Association between lean mass, fat mass, and bone mineral density: a meta-analysis. , 2014, The Journal of clinical endocrinology and metabolism.

[3]  Walter C Willett,et al.  Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. , 2007, American journal of epidemiology.

[4]  B. Zinman,et al.  Rosiglitazone-Associated Fractures in Type 2 Diabetes , 2008, Diabetes Care.

[5]  M. Bouxsein,et al.  Defects in cortical microarchitecture among African-American women with type 2 diabetes , 2015, Osteoporosis International.

[6]  T. Therneau,et al.  Fracture Risk in Type 2 Diabetes: Update of a Population‐Based Study , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  T. Kislinger,et al.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. , 2000, The Journal of clinical investigation.

[8]  M. Saito,et al.  Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats , 2006, Osteoporosis International.

[9]  L. Melton,et al.  Osteoporosis assessment by whole body region vs. site-specific DXA , 2005, Osteoporosis International.

[10]  C. Fiore,et al.  Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. , 2012, The Journal of clinical endocrinology and metabolism.

[11]  Steven Boonen,et al.  Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. , 2010, The Journal of endocrinology.

[12]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[13]  Vilmundur Gudnason,et al.  Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults. , 2013, The Journal of clinical endocrinology and metabolism.

[14]  M. Vitai,et al.  [Effect of progressive insulin resistance on the correlation of glucose metabolism and bone status]. , 2007, Orvosi hetilap.

[15]  Y. Azuma,et al.  Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. , 2000, The Journal of clinical investigation.

[16]  H. Beck-Nielsen,et al.  Correlations between insulin sensitivity and bone mineral density in non‐diabetic men , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[17]  R. DePinho,et al.  Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism , 2010, Cell.

[18]  R. Rizzoli,et al.  Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent Retirees , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  J. Gustafsson,et al.  Muscle GLUT4 regulation by estrogen receptors ERβ and ERα , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Bazzocchi,et al.  DXA: Technical aspects and application. , 2016, European journal of radiology.

[21]  Seung Hun Lee,et al.  Insulin resistance and composite indices of femoral neck strength in Asians: the fourth Korea National Health and Nutrition Examination Survey (KNHANES IV) , 2016, Clinical endocrinology.

[22]  Karen C Johnson,et al.  Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. , 2006, The Journal of clinical endocrinology and metabolism.

[23]  M. Vitai,et al.  Relations between bone status and glucose metabolism with progression of insulin resistance , 2007 .

[24]  R. Bergman,et al.  Failure of Homeostatic Model Assessment of Insulin Resistance to Detect Marked Diet-Induced Insulin Resistance in Dogs , 2014, Diabetes.

[25]  T. Yuen,et al.  The myokine irisin increases cortical bone mass , 2015, Proceedings of the National Academy of Sciences.

[26]  R. Recker,et al.  Relationship of obesity with osteoporosis. , 2007, The Journal of clinical endocrinology and metabolism.

[27]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[28]  L. McCabe,et al.  Normal bone density obtained in the absence of insulin receptor expression in bone. , 2006, Endocrinology.

[29]  T. Hangartner,et al.  Comparison of absorptiometric evaluations from total-body and local-regional skeletal scans. , 2000, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[30]  Minqi Li,et al.  Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. , 2007, Cell metabolism.

[31]  S. Ozmen,et al.  Insulin resistance in type 2 diabetes mellitus may be related to bone mineral density. , 2012, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[32]  K. Taylor,et al.  Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait. , 2005, Diabetes.

[33]  S. Otani,et al.  Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism. , 1999, Metabolism: clinical and experimental.

[34]  K. Taylor,et al.  Lipoprotein lipase is a gene for insulin resistance in Mexican Americans. , 2004, Diabetes.

[35]  N. Watts,et al.  Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus. , 2016, The Journal of clinical endocrinology and metabolism.

[36]  R. Lindsay,et al.  Males Have Larger Skeletal Size and Bone Mass Than Females, Despite Comparable Body Size , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  C. Cooper,et al.  Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance? , 2004, Diabetologia.

[38]  Sang Min Park,et al.  Association between insulin resistance and bone mass in men. , 2014, The Journal of clinical endocrinology and metabolism.

[39]  S. Cummings,et al.  Older women with diabetes have an increased risk of fracture: a prospective study. , 2001, The Journal of clinical endocrinology and metabolism.